Outcomes of a Novel Belatacept-Based Regimen - Beyond 2 Years of Follow-Up.
Publication
, Conference
Katz-Greenberg, G; Byrns, J
Published in: AMERICAN JOURNAL OF TRANSPLANTATION
2022
Duke Scholars
Published In
AMERICAN JOURNAL OF TRANSPLANTATION
EISSN
1600-6143
ISSN
1600-6135
Publication Date
2022
Volume
22
Start / End Page
1088 / 1088
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Katz-Greenberg, G., & Byrns, J. (2022). Outcomes of a Novel Belatacept-Based Regimen - Beyond 2 Years of Follow-Up. In AMERICAN JOURNAL OF TRANSPLANTATION (Vol. 22, pp. 1088–1088).
Katz-Greenberg, G., and J. Byrns. “Outcomes of a Novel Belatacept-Based Regimen - Beyond 2 Years of Follow-Up.” In AMERICAN JOURNAL OF TRANSPLANTATION, 22:1088–1088, 2022.
Katz-Greenberg G, Byrns J. Outcomes of a Novel Belatacept-Based Regimen - Beyond 2 Years of Follow-Up. In: AMERICAN JOURNAL OF TRANSPLANTATION. 2022. p. 1088–1088.
Katz-Greenberg, G., and J. Byrns. “Outcomes of a Novel Belatacept-Based Regimen - Beyond 2 Years of Follow-Up.” AMERICAN JOURNAL OF TRANSPLANTATION, vol. 22, 2022, pp. 1088–1088.
Katz-Greenberg G, Byrns J. Outcomes of a Novel Belatacept-Based Regimen - Beyond 2 Years of Follow-Up. AMERICAN JOURNAL OF TRANSPLANTATION. 2022. p. 1088–1088.
Published In
AMERICAN JOURNAL OF TRANSPLANTATION
EISSN
1600-6143
ISSN
1600-6135
Publication Date
2022
Volume
22
Start / End Page
1088 / 1088
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences
- 11 Medical and Health Sciences